Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Financial Info > Press Releases
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
COVANCE TO PRESENT AT BAIRD'S 2003 GROWTH STOCK CONFERENCE
Princeton, New Jersey, May 12, 2003 — Covance Inc. (NYSE: CVD) will participate in the Robert W. Baird & Co. 2003 Growth Stock Conference in Chicago, Illinois on Wednesday, May 14, 2003 at 4:15 p.m. CST. Joe Herring, Covance's President and Chief Operating Officer, will make a formal presentation at the event.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2002 net revenues of $883 million, global operations in 17 countries, and approximately 6,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website in the About Covance area.
SEC Filings
Annual Reports
Quarterly Reports
Press Releases